Buhisan, May Ann .
HRN: 04-00-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2024
AMPICILLIN 1GM (VIAL)
06/26/2024
06/28/2024
IV
2gm
Q6
Prom
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes